Novel Antibody Looks Promising in Lupus Nephritis Novel Antibody Looks Promising in Lupus Nephritis
A highly engineered anti-CD20 antibody, obinutuzumab, enhances renal responses in lupus nephritis compared with standard immunotherapy and is well tolerated. A Phase 3 study is planned for 2020.Medscape Medical News
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Nephrology News Source Type: news
More News: Immunotherapy | Lupus | Nephritis | Study | Transplant Surgery | Transplants | Urology & Nephrology